1 - 25 of 267 results for author:"Miller W." in Literature citations
Results Customize
› Repeat search in UniProtKB (160,535)
| Using major outer membrane protein typing as an epidemiological tool to investigate outbreaks caused by milk-borne Campylobacter jejuni isolates in California. Jay-Russell M.T., Mandrell R.E., Yuan J., Bates A., Manalac R., Mohle-Boetani J., Kimura A., Lidgard J., Miller W.G. J. Clin. Microbiol. 51:195-201(2013) · UniProtKB (12) |
| Polar and brown bear genomes reveal ancient admixture and demographic footprints of past climate change. Miller W., Schuster S.C., Welch A.J., Ratan A., Bedoya-Reina O.C., Zhao F., Kim H.L., Burhans R.C., Drautz D.I., Wittekindt N.E. et al. Proc. Natl. Acad. Sci. U.S.A. 109:E2382-90(2012) · UniProtKB (65) |
| Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity. Axten J.M., Medina J.R., Blackledge C.W., Duquenne C., Grant S.W., Bobko M.A., Peng T., Miller W.H., Pinckney T., Gallagher T.F. et al. Bioorg. Med. Chem. Lett. 22:4028-4032(2012) · Mapped (1) |
| Defining MC1R regulation in human melanocytes by its agonist alpha-melanocortin and antagonists agouti signaling protein and beta-defensin 3. Swope V.B., Jameson J.A., McFarland K.L., Supp D.M., Miller W.E., McGraw D.W., Patel M.A., Nix M.A., Millhauser G.L., Babcock G.F. et al. J. Invest. Dermatol. 132:2255-2262(2012) · Mapped (23) |
| Mechanistic insight into pertussis toxin and lectin signaling using T cells engineered to express a CD8alpha/CD3zeta chimeric receptor. Schneider O.D., Millen S.H., Weiss A.A., Miller W.E. Biochemistry 51:4126-4137(2012) · Mapped (7) |
| Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation. Apostolidis P.A., Lindsey S., Miller W.M., Papoutsakis E.T. Physiol. Genomics 44:638-650(2012) · Mapped (32) |
| Effect of P450 oxidoreductase variants on the metabolism of model substrates mediated by CYP2C9.1, CYP2C9.2, and CYP2C9.3. Subramanian M., Agrawal V., Sandee D., Tam H.K., Miller W.L., Tracy T.S. Pharmacogenet. Genomics 22:590-597(2012) · Mapped (16) |
| Interaction of the trans-frame potyvirus protein P3N-PIPO with host protein PCaP1 facilitates potyvirus movement. Vijayapalani P., Maeshima M., Nagasaki-Takekuchi N., Miller W.A. PLoS Pathog. 8:E1002639-E1002639(2012) · UniProtKB (2) · Mapped (2) |
| Expression of P450c17 in the human fetal nervous system. Schonemann M.D., Muench M.O., Tee M.K., Miller W.L., Mellon S.H. Endocrinology 153:2494-2505(2012) · Mapped (3) |
| Evolutionary silence of the acid chaperone protein HdeB in enterohemorrhagic Escherichia coli O157:H7. Carter M.Q., Louie J.W., Fagerquist C.K., Sultan O., Miller W.G., Mandrell R.E. Appl. Environ. Microbiol. 78:1004-1014(2012) · UniProtKB (5) |
| The syndrome of 17,20 lyase deficiency. Miller W.L. J. Clin. Endocrinol. Metab. 97:59-67(2012) · Mapped (3) |
| ERalpha-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer. Miller T.W., Balko J.M., Fox E.M., Ghazoui Z., Dunbier A., Anderson H., Dowsett M., Jiang A., Smith R.A., Maira S.M. et al. Cancer Discov 1:338-351(2011) · Mapped (58) |
| Role of tumor suppressor p53 in megakaryopoiesis and platelet function. Apostolidis P.A., Woulfe D.S., Chavez M., Miller W.M., Papoutsakis E.T. Exp. Hematol. 40:131-42.e4(2012) · Mapped (18) |
| Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. Orchard P.J., Lund T., Miller W., Rothman S.M., Raymond G., Nascene D., Basso L., Cloyd J., Tolar J. J Neuroinflammation 8:144-144(2011) · Mapped (3) |
| RIG-I is required for the inhibition of measles virus by retinoids. Soye K.J., Trottier C., Richardson C.D., Ward B.J., Miller W.H. Jr. PLoS ONE 6:e22323-e22323(2011) · Mapped (5) |
| Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Fluck C.E., Meyer-Boni M., Pandey A.V., Kempna P., Miller W.L., Schoenle E.J., Biason-Lauber A. Am. J. Hum. Genet. 89:201-218(2011) · UniProtKB (2) |
| Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration. Wu W., Cheng Y., Keller C.A., Ernst J., Kumar S.A., Mishra T., Morrissey C., Dorman C.M., Chen K.B., Drautz D. et al. Genome Res. 21:1659-1671(2011) · Mapped (1) |
| Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Horowitz N.A., Blevins E.A., Miller W.M., Perry A.R., Talmage K.E., Mullins E.S., Flick M.J., Queiroz K.C., Shi K., Spek C.A. et al. Blood 118:2889-2895(2011) · Mapped (3) |
| Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil). Miller W., Hayes V.M., Ratan A., Petersen D.C., Wittekindt N.E., Miller J., Walenz B., Knight J., Qi J., Zhao F. et al. Proc. Natl. Acad. Sci. U.S.A. 108:12348-12353(2011) · UniProtKB (22,403) |
| The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Flick M.J., Chauhan A.K., Frederick M., Talmage K.E., Kombrinck K.W., Miller W., Mullins E.S., Palumbo J.S., Zheng X., Esmon N.L. et al. Blood 117:6326-6337(2011) · Mapped (5) |
| Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer. Pettersson F., Yau C., Dobocan M.C., Culjkovic-Kraljacic B., Retrouvey H., Retrouvay H., Puckett R., Flores L.M., Krop I.E., Rousseau C. et al. Clin. Cancer Res. 17:2874-2884(2011) · Mapped (2) |
| Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms. Tee M.K., Huang N., Damm I., Miller W.L. Mol. Endocrinol. 25:715-731(2011) · Mapped (9) |
| A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance. Miller T.W., Balko J.M., Ghazoui Z., Dunbier A., Anderson H., Dowsett M., Gonzalez-Angulo A.M., Mills G.B., Miller W.R., Wu H. et al. Clin. Cancer Res. 17:2024-2034(2011) · Mapped (7) |
| Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Medina J.R., Becker C.J., Blackledge C.W., Duquenne C., Feng Y., Grant S.W., Heerding D., Li W.H., Miller W.H., Romeril S.P. et al. J. Med. Chem. 54:1871-1895(2011) · Mapped (1) |
| Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia. Sahakitrungruang T., Tee M.K., Blackett P.R., Miller W.L. J. Clin. Endocrinol. Metab. 96:792-798(2011) · Mapped (6) |